Related Experiment Video

Updated: Jul 13, 2026

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
11:42

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

[Vessel-platelet and coagulation components of hemostasis in patients with chronic tubulointerstitial nephritis]

T S Suvorova, N L Tov, E A Movchan

    Terapevticheskii Arkhiv
    |August 10, 2007
    PubMed

    Insights

    Chronic tubulointerstitial nephritis (CTIN) involves significant activation of the hemostasis system, including platelet hyperaggregation and hypercoagulation. These hemostatic changes correlate with disease activity, aiding in its assessment.

    Area of Science:

    • Nephrology
    • Hematology
    • Pathophysiology

    Context:

    • Chronic tubulointerstitial nephritis (CTIN) is a kidney disease with complex pathophysiology.
    • The role of the hemostasis system in CTIN progression and activity requires further elucidation.

    Purpose:

    • To investigate the vessel-platelet and coagulation components of the hemostasis system in patients with CTIN.
    • To determine the correlation between hemostatic markers and clinical characteristics, including disease activity, blood pressure, renal function, and duration of CTIN.

    Summary:

    • Patients with CTIN exhibit activated vessel-platelet hemostasis, evidenced by decreased platelet counts, persistent platelet hyperaggregation, and elevated levels of Willebrand factor.
    • Coagulation changes include accelerated activated partial thromboplastin time, background thrombinemia indicated by soluble fibrin-monomeric complexes (SFMC), and hypercoagulation.
    • These findings suggest a latent course of renal intravascular blood coagulation in CTIN.

    Impact:

    • The study highlights that hemostasis system activation is a key feature of CTIN.
    • Assessing hemostatic markers can provide valuable insights into the activity and progression of chronic tubulointerstitial nephritis.
    Abstract

    More Related Videos

    A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time09:38

    A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

    Published on: February 14, 2017

    Related Concept Videos

    Formation of the Platelet Plug01:22

    Formation of the Platelet Plug

    The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
    As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
    Introduction to Hemostasis01:05

    Introduction to Hemostasis

    Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
    The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
    Structure and Function of Platelets01:18

    Structure and Function of Platelets

    The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
    Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
    Clot Retraction and Fibrinolysis01:16

    Clot Retraction and Fibrinolysis

    After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
    Extrinsic and Intrinsic Pathways of Hemostasis01:20

    Extrinsic and Intrinsic Pathways of Hemostasis

    Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
    The Extrinsic Pathway
    The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...